PCRX
Pacira BioSciences, Inc.
25.20$
+0.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.7% | -5.0% | +2.4% | -5.1% | +17.4% | -5.7% | +12.7% | -0.8% | +14.0% | -4.0% | +12.4% | +2.0% | +16.9% | -13.7% | -28.6% | +55.6% | +11.5% | -9.1% | +13.9% | -5.8% | +24.6% | -0.8% | +7.2% | -1.1% | +2.7% | -6.8% | +5.7% | -3.3% | +10.6% | -7.8% | +6.5% | -5.3% | +11.1% | -9.8% | +7.2% | -0.9% | +9.7% | -9.9% | +8.5% | – | |
| – | -45.3% | +4.1% | -3.1% | -23.4% | +16.8% | +7.5% | -8.6% | -8.8% | +25.8% | +13.9% | -7.7% | -11.5% | +43.0% | -6.8% | -25.0% | +34.5% | +17.7% | -11.2% | +12.4% | -1.7% | +12.6% | -7.5% | +40.3% | +0.1% | +22.2% | -20.8% | -1.7% | -17.5% | +20.0% | -0.6% | -6.7% | -12.2% | +2.6% | -14.0% | +19.1% | -16.1% | +17.6% | -9.6% | +21.3% | – | |
| – | +95.5% | -9.3% | +5.4% | +4.2% | +17.7% | -10.5% | +22.2% | +1.9% | +10.5% | -10.0% | +20.9% | +6.4% | +9.9% | -16.1% | -30.0% | +64.5% | +9.4% | -8.4% | +14.4% | -7.2% | +29.1% | +1.4% | -2.6% | -1.7% | -5.8% | +1.2% | +8.9% | +2.4% | +7.6% | -10.4% | +11.7% | -3.0% | +13.6% | -8.7% | +4.2% | +3.6% | +7.8% | -10.0% | +5.2% | – | |
| – | +75.0% | -2.6% | +13.4% | -37.6% | -14.8% | +43.4% | -14.9% | +21.7% | -4.9% | +1.5% | +23.9% | +13.6% | -3.0% | -19.5% | -13.9% | +7.6% | +4.6% | +3.6% | -20.8% | -7.9% | +34.0% | +39.3% | +21.6% | -26.2% | -9.8% | -2.1% | +9.8% | +10.7% | -6.6% | -6.3% | +11.5% | -6.1% | +25.1% | +6.0% | +11.3% | -7.9% | +44.2% | -25.0% | +7.7% | – | |
| – | +0.5% | +13.8% | 0.0% | -5.0% | +3.9% | +14.0% | -10.2% | -1.8% | +1.8% | -1.0% | -0.9% | +8.3% | +11.7% | -17.1% | +6.6% | +7.6% | +6.7% | +3.8% | +5.3% | -4.4% | +1.3% | +18.2% | +9.0% | -2.0% | +1.4% | +4.6% | -6.4% | +8.4% | +1.3% | +8.4% | -10.8% | +7.1% | -6.0% | +6.6% | +20.5% | -11.4% | +20.0% | -10.6% | +156.6% | – | |
| – | +12.3% | +13.5% | -0.6% | -10.3% | -6.1% | +19.0% | -3.6% | +4.6% | -0.4% | +6.9% | +9.3% | +5.3% | +22.7% | -33.7% | +2.5% | +15.8% | +10.1% | -11.3% | -4.0% | -5.9% | +88.2% | -9.9% | -16.2% | +9.1% | +25.6% | -4.6% | -28.9% | +30.8% | -5.7% | +6.1% | -0.9% | +155.1% | -54.4% | +8.1% | -0.7% | +5.4% | +10.4% | -11.1% | +5.6% | – | |
| – | – | – | – | – | – | -182.0% | – | -38.1% | +202.9% | -91.2% | +388.9% | -54.3% | -29.0% | +897.3% | -141.8% | – | +6.6% | +3.5% | +79.3% | -9.8% | -86.6% | +313.0% | +79.6% | -31.8% | -146.5% | – | – | -55.6% | +87.2% | -60.2% | +113.7% | -594.1% | – | -91.9% | +327.1% | -25.1% | -49.8% | +44.9% | -7.7% | – | |
| – | +16.1% | +39.3% | +101.9% | -1.9% | -0.4% | +1.0% | +4.7% | +4.5% | +2.0% | +1.1% | +1.1% | +1.1% | +1.0% | +0.4% | -9.4% | +30.7% | -1.0% | -1.3% | +0.7% | +4.4% | +42.1% | -1.7% | -13.8% | +11.6% | +12.0% | -13.2% | -59.7% | -10.4% | -2.2% | -2.1% | -5.9% | +50.2% | -18.2% | +19.5% | +2.5% | -22.2% | -7.7% | -5.8% | +14.0% | – | |
| – | – | – | – | – | – | -329.9% | – | -127.0% | – | -130.3% | – | -616.1% | – | – | -185.4% | – | +106.4% | +0.2% | +101.6% | -5.5% | -125.6% | – | +201.7% | -90.6% | -973.3% | – | – | -56.1% | +103.1% | -59.5% | +168.2% | -479.6% | – | -65.9% | -122.1% | – | -94.0% | +775.3% | -48.9% | – | |
| – | -158.3% | – | +0.0% | +50.0% | -22.2% | +0.0% | +0.0% | -277.1% | – | +583.8% | -733.6% | – | +397.0% | -70.5% | -110.6% | – | – | – | +178.9% | +0.1% | -116.3% | – | +357.3% | +29.6% | -388.4% | – | – | -52.5% | +54.1% | -47.3% | +279.7% | -74.0% | +105.7% | -58.9% | -25.0% | +40.1% | -126.1% | – | -200.8% | – | |
| – | – | – | – | – | – | -332.4% | – | -125.0% | – | -133.4% | – | -323.0% | – | – | -189.1% | – | -88.8% | -28.6% | +84.0% | -7.4% | -129.0% | – | +191.1% | -103.5% | – | – | – | -57.9% | +129.0% | -63.9% | +110.3% | -859.6% | – | -70.0% | -200.7% | – | -69.9% | +78.1% | +59.6% | – | |
| – | – | -1,357.2% | – | – | +1,331.0% | -120.4% | – | -22.1% | +114.7% | -64.3% | +83.2% | +1.1% | -40.7% | +166.6% | -85.8% | +557.6% | +36.6% | -1.2% | +54.5% | -0.8% | -54.9% | +120.3% | +39.7% | -38.6% | -29.7% | -91.9% | +3,275.4% | -37.1% | +45.2% | -36.8% | +68.8% | -295.9% | – | -33.6% | -13.0% | +17.5% | -26.4% | +16.7% | -13.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.